Kite Pharma is a publicly held, clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. The Santa Monica, California-based company was founded in 2009 by Arie Belldegrun, M.D., FACS, an Israeli-American oncologist, who serves as the company's chairman, president and chief executive officer.

Property Value
dbo:abstract
  • Kite Pharma is a publicly held, clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. The Santa Monica, California-based company was founded in 2009 by Arie Belldegrun, M.D., FACS, an Israeli-American oncologist, who serves as the company's chairman, president and chief executive officer. (en)
dbo:foundedBy
dbo:foundingYear
  • 2009-01-01 (xsd:date)
dbo:industry
dbo:keyPerson
dbo:locationCity
dbo:locationCountry
dbo:product
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 42800298 (xsd:integer)
dbo:wikiPageRevisionID
  • 731660930 (xsd:integer)
dct:subject
rdf:type
rdfs:comment
  • Kite Pharma is a publicly held, clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. The Santa Monica, California-based company was founded in 2009 by Arie Belldegrun, M.D., FACS, an Israeli-American oncologist, who serves as the company's chairman, president and chief executive officer. (en)
rdfs:label
  • Kite Pharma (en)
owl:sameAs
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Kite Pharma, Inc. (en)
is dbo:wikiPageRedirects of
is foaf:primaryTopic of